Erika Adriana Eksioglu

8PUBLICATIONS
40CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Innate immunityShip and platform structures (incl. maritime hydrodynamics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 12, 2026
Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells.

Alexandra Calescibetta, Robert Dalton, Nicole Fortenbery

|Jul 28, 2025
Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL.

Angimar Uriepero-Palma, Maria Elena Márquez, Eugenia Payque

|May 07, 2024
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.

Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall

|Feb 25, 2023
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic Syndromes.

Grace A Ward, Robert P Dalton, Benjamin S Meyer

|Jan 30, 2021
Constitutively Activated DAP12 Induces Functional Anti-Tumor Activation and Maturation of Human Monocyte-Derived DC.

Robert Dalton, Alexandra Calescibetta, Jun Min Zhou

|Feb 11, 2020
MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma.

Wendy M Kandell, Sarah S Donatelli, Thu Le Trinh

Pageof 2

Frequent Collaborators

3 joint publications

Grace Ward

2 joint publications

Nicole D Vincelette

1 joint publications

Wendy M Kandell

1 joint publications

Thu Le Trinh